Autologous Matrix-induced Chondrogenesis Help Repair Articular Cartilage Damage
Autologous matrix-induced chondrogenesis is used to treat articular cartilage damage with the combination of micro-fracture surgery and application of a bi-layer collagen I/III membrane. Currently, there are limited long-term benefits, as the potential benefits have not been documented and there is no evidence that autologous matrix -induced chondrogenesis improves arthritis pain or quality of life in patients with moderate to severe osteoarthritis. Osteoarthritis is the most common type of joint disease, which affects more than 32.5 million adults in the U.S. Moreover, it is the most common form of arthritis, affects around 8.75 million people (aged 45 and over) in the U.K., and up to 10% of the adult and 20% of the elderly population in Singapore. Furthermore, in Italy, the number of people affected by these chronic diseases went from 10.3 million individuals in 2010 to 9.8 million by the end of 2018. Autologous matrix-induced chondrogenesis is considered min...